NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957–80.

Article  Google Scholar 

Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-Induced Hypertension. Circ Res. 2015;116:991–1006.

Article  PubMed  PubMed Central  Google Scholar 

Shariq OA, McKenzie TJ. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland Surg. 2020;9:80–93.

Article  PubMed  PubMed Central  Google Scholar 

Hall ME, Cohen JB, Ard JD, Egan BM, Hall JE, Lavie CJ, Ma J, Ndumele CE, Schauer PR, Shimbo D. (2021) Weight-Loss Strategies for Prevention and Treatment of Hypertension: A Scientific Statement from the American Heart Association. Hypertension E38–E50.

Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118:1723–35.

Article  PubMed  PubMed Central  Google Scholar 

Klop B, Elte JWF, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5:1218–40.

Article  PubMed  PubMed Central  Google Scholar 

Drager LF, Bortolotto LA, Figueiredo AC, Silva BC, Krieger EM, Lorenzi-Filho G. Obstructive sleep apnea, hypertension, and their interaction on arterial stiffness and heart remodeling. Chest. 2007;131:1379–86.

Article  PubMed  Google Scholar 

Hallersund P, Sjöström L, Olbers T, Lönroth H, Jacobson P, Wallenius V, et al. Gastric bypass surgery is followed by lowered blood pressure and increased diuresis - long term results from the Swedish obese subjects (SOS) study. PLoS ONE. 2012;7:e49696.

Article  PubMed  PubMed Central  Google Scholar 

Adams TD, Davidson LE, Litwin SE, et al. Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 2017;377:1143–55.

Article  PubMed  PubMed Central  Google Scholar 

Stenberg E, Cao Y, Marsk R, Sundbom M, Jernberg T, Näslund E. Association between metabolic surgery and cardiovascular outcome in patients with hypertension: A nationwide matched cohort study. PLoS Med. 2020. https://doi.org/10.1371/journal.pmed.1003307.

Article  PubMed  PubMed Central  Google Scholar 

Stenberg E, Marsk R, Sundbom M, Ottosson J, Jernberg T, Näslund I, et al. Remission, relapse, and risk of major cardiovascular events after metabolic surgery in persons with hypertension: A Swedish nationwide registry-based cohort study. PLoS Med. 2021;18:e1003817.

Article  PubMed  PubMed Central  Google Scholar 

Näslund E, Stenberg E, Hofmann R, Ottosson J, Sundbom M, Marsk R, Svensson P, Szummer K, Jernberg T. Association of metabolic surgery with major adverse cardiovascular outcomes in patients with previous myocardial infarction and severe obesity: A nationwide cohort study. Circulation. 2021;143:1458–67.

Article  PubMed  Google Scholar 

Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98:1763–77.

Article  PubMed  Google Scholar 

Wiggins T, Guidozzi N, Welbourn R, Ahmed AR, Markar SR. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: A systematic review and meta-analysis. PLoS Med. 2020. https://doi.org/10.1371/journal.pmed.1003206.

Article  PubMed  PubMed Central  Google Scholar 

Wölnerhanssen BK, Peterli R, Hurme S, et al. Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: 5-year outcomes of merged data from two randomized clinical trials (SLEEVEPASS and SM-BOSS). Br J Surg. 2021;108:49–57.

Article  PubMed  Google Scholar 

Salminen P, Grönroos S, Helmiö M, Hurme S, Juuti A, Juusela R, et al. Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial. JAMA Surg. 2022;157:656–66.

Article  PubMed  PubMed Central  Google Scholar 

Kraljevic M, Süsstrunk J, Wölnerhanssen BK, Peters T, Bueter M, Gero D, et al. Long-term outcomes of laparoscopic Roux-en-Y gastric bypass vs laparoscopic sleeve gastrectomy for obesity: the SM-BOSS randomized clinical trial. JAMA Surg. 2025. https://doi.org/10.1001/jamasurg.2024.7052.

Article  PubMed  Google Scholar 

Hauge JW, Borgeraas H, Birkeland KI, et al. Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2025. https://doi.org/10.1016/S2213-8587(24)00396-6.

Article  Google Scholar 

Kirwan JP, Courcoulas AP, Cummings DE, et al. Diabetes remission in the alliance of randomized trials of medicine versus metabolic surgery in type 2 diabetes (ARMMS-T2D). Diabetes Care. 2022;45:1574–83.

Article  PubMed  PubMed Central  Google Scholar 

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric–metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2015;386:964–73.

Article  PubMed  Google Scholar 

Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes — 5-year outcomes. N Engl J Med. 2017;376:641–51.

Article  PubMed  PubMed Central  Google Scholar 

Ikramuddin S, Korner J, Lee WJ, et al. Lifestyle intervention and medical management with vs without roux-en-y gastric bypass and control of hemoglobin a1c, ldl cholesterol, and systolic blood pressure at 5 years in the diabetes surgery study. JAMA. 2018;319:266–78.

Article  PubMed  PubMed Central  Google Scholar 

Schiavon CA, Ikeoka DT, de Sousa MG, Silva CRA, Bersch-Ferreira AC, de Oliveira JD, Noujaim PM, Cohen RV, Amodeo C, Berwanger O. Effects of gastric bypass surgery in patients with hypertension: rationale and design for a randomised controlled trial (GATEWAY study). BMJ Open. 2014;4:e005702–005702.

Article  PubMed  PubMed Central  Google Scholar 

Schiavon CA, Bersch-Ferreira AC, Santucci EV, et al. Effects of bariatric surgery in obese patients with hypertension the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension). Circulation. 2018;137:1132.

Article  PubMed  Google Scholar 

Schiavon CA, Ikeoka D, Santucci EV, et al. Effects of bariatric surgery versus medical therapy on the 24-hour ambulatory blood pressure and the prevalence of resistant hypertension: the GATEWAY randomized clinical trial. Hypertension. 2019;73:571–7.

Article  PubMed  Google Scholar 

Furlan SF, Drager LF, Santos RN, et al. Three-year effects of bariatric surgery on obstructive sleep apnea in patients with obesity grade 1 and 2: a sub-analysis of the GATEWAY trial. Int J Obes. 2021;45:914–7.

Article  Google Scholar 

Schiavon CA, Cavalcanti AB, Oliveira JD, et al. Randomized trial of effect of bariatric surgery on blood pressure after 5 years. J Am Coll Cardiol. 2024;83:637–48.

Article  PubMed  Google Scholar 

Oliveira JD, Schiavon CA, Oliveira JS, et al. Shorter history of hypertension as a predictor of hypertension remission after 3-years of bariatric surgery: data from the GATEWAY trial. Obes Surg. 2023;33:2485–92.

Article  PubMed  Google Scholar 

Benaiges D, Saguéa M, Roux F-L JA, et al. Predictors of hypertension remission and recurrence after bariatric surgery. Am J Hypertens. 2016;29:653–9.

Article  PubMed  Google Scholar 

Hall JE, Hall ME. Cardiometabolic surgery for treatment of hypertension? Hypertension. 2019;73:543–6.

Article  PubMed  Google Scholar 

Sandoval DA, D’alessio DA. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease. Physiol Rev. 2015;95:513–48.

Article  PubMed  Google Scholar 

Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, et al. Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of the obesity society and the American society of hypertension Landsberg et al. obesity related hypertension. J Clin Hypertens. 2013;15:14–33.

Article  Google Scholar 

Fenske WK, Dubb S, Bueter M, Seyfried F, Patel K, Tam FWK, et al. Effect of bariatric surgery-induced weight loss on renal and systemic inflammation and blood pressure: a 12-month prospective study. Surg Obes Relat Dis. 2013;9:559–68.

Article  PubMed